- Home
- INSM vs LYB Comparison
INSM vs LYB Comparison
Compare INSM & LYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSM
- LYB
- Stock Information
- Founded
- INSM 1988
- LYB 1955
- Country
- INSM United States
- LYB United States
- Employees
- INSM N/A
- LYB N/A
- Industry
- INSM Biotechnology: Pharmaceutical Preparations
- LYB Major Chemicals
- Sector
- INSM Health Care
- LYB Industrials
- Exchange
- INSM Nasdaq
- LYB Nasdaq
- Market Cap
- INSM 17.3B
- LYB 18.5B
- IPO Year
- INSM 2000
- LYB N/A
- Fundamental
- Price
- INSM $98.24
- LYB $62.58
- Analyst Decision
- INSM Strong Buy
- LYB Hold
- Analyst Count
- INSM 17
- LYB 13
- Target Price
- INSM $106.80
- LYB $68.62
- AVG Volume (30 Days)
- INSM 6.2M
- LYB 4.3M
- Earning Date
- INSM 08-07-2025
- LYB 08-01-2025
- Dividend Yield
- INSM N/A
- LYB 8.76%
- EPS Growth
- INSM N/A
- LYB N/A
- EPS
- INSM N/A
- LYB 3.25
- Revenue
- INSM $381,030,000.00
- LYB $39,675,000,000.00
- Revenue This Year
- INSM $28.03
- LYB N/A
- Revenue Next Year
- INSM $120.54
- LYB $2.93
- P/E Ratio
- INSM N/A
- LYB $19.22
- Revenue Growth
- INSM 20.77
- LYB 1.30
- 52 Week Low
- INSM $60.40
- LYB $51.11
- 52 Week High
- INSM $106.83
- LYB $100.46
- Technical
- Relative Strength Index (RSI)
- INSM 62.07
- LYB 62.56
- Support Level
- INSM $98.85
- LYB $57.48
- Resistance Level
- INSM $106.83
- LYB $59.50
- Average True Range (ATR)
- INSM 3.17
- LYB 1.58
- MACD
- INSM -0.86
- LYB 0.34
- Stochastic Oscillator
- INSM 20.61
- LYB 95.13
About INSM Insmed Incorporated
Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.
About LYB LyondellBasell Industries NV (Netherlands)
LyondellBasell is a petrochemical producer with operations in the United States, Europe, and Asia. The company is the world's largest producer of polypropylene and also a major producer of polyethylene and propylene oxide. Its chemicals are used in various consumer and industrial end products. Well over half of LyondellBasell's production comes from its North American operations.